FDA Adverse Event Injury Summary report: N

INTRALASE FS2

MDR report key: 6896544 · Received September 27, 2017

Report

Report Number
3006695864-2017-00802
Event Type
Injury
Date Received
September 27, 2017
Date of Event
September 1, 2017
Report Date
October 31, 2017
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HNO
UDI-DI
05050474573451
PMA / PMN Number
K060372
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION: A REVIEW OF THE RECORDS RELATED TO THE DEVICE THAT INCLUDED LABELING, MANUALS, TRENDING, AND RISK DOCUMENTATION WAS PERFORMED. THE TREND REVIEW SHOWS THAT THERE IS NOT SIGNIFICANT CHANGE OVER HISTORICAL COMPLAINT LIMITS AND NO RECOGNIZABLE ADVERSE TREND. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE COMPLAINT ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. THERE WAS NO PRODUCT DEFICIENCY IDENTIFIED. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Description of Event or Problem · 1

THE SURGERY CENTER REPORTED THAT A LASER VISION CORRECTION PATIENT PRESENTED WITH TRANSIENT LIGHT SENSITIVITY IN BOTH EYES (OU) AT THE 3 MONTH POST-OPERATIVE EXAM. THE PATIENT¿S COMMENTS WERE DIFFICULT TO WORK AND DIFFICULTY KEEPING EYES OPEN. IT WAS INDICATED THAT THE EVENT WAS LASTING AND DISABLING, SIGNIFICANTLY INTERFERING WITH DAILY ACTIVITIES. TOPICAL STEROID DOSAGE WAS INCREASED TO TREAT THE SYMPTOMS. BCVA FROM (B)(6) 2017: RIGHT EYE PRE-OP 20/15 -5.50 X -.75 X 0, LEFT EYE PRE-OP 20/15 -5.50 X -1.25 X 0. ON (B)(6) 2017 UNCORRECTED VISUAL ACUITY (UCVA) 20/20.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
676255 INTRALASE FS2 FEMTOSECOND LASER HNO ABBOTT MEDICAL OPTICS 20005D 05050474573451

Patients

Seq Age Sex Outcome Treatment
1 36 YR Required Intervention WAVELIGHT SERIAL NO. (B)(4)